Search
GSK's Oral Small Molecule Targeted Drug Set for Priority Review
4 day ago /
Read about 0 minute
Author：小编
China's National Medical Products Administration's Center for Drug Evaluation has announced that GSK's linaclotide tablets are slated for priority review for the treatment of cholestatic pruritus in adult patients with primary biliary cholangitis (PBC). Notably, this drug has already received orphan drug status from both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
